Identifying pulmonary hypertension in patients with interstitial lung disease – Evaluating an unmet need

C. A. Benjamin-Smith, A. M. Higton, B. Madden, F. Chua (London, United Kingdom)

Source: Annual Congress 2010 - Pulmonary circulation III
Session: Pulmonary circulation III
Session type: Thematic Poster Session
Number: 1142
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. A. Benjamin-Smith, A. M. Higton, B. Madden, F. Chua (London, United Kingdom). Identifying pulmonary hypertension in patients with interstitial lung disease – Evaluating an unmet need. Eur Respir J 2010; 36: Suppl. 54, 1142

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option?
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011


The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Eur Respir J, 51 (1) 1702596; 10.1183/13993003.02596-2017
Year: 2018



Treatment of pulmonary hypertension due to COPD: can we really hope in better?
Source: Eur Respir J 2005; 26: Suppl. 49, 562s
Year: 2005

Does pulmonary rehabilitation improve mortality in patients with chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

Recruitment for psychological therapy in chronic obstructive pulmonary disease (COPD) What factors influence participation?
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016


Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Risk assessment in severe pulmonary hypertension due to interstitial lung disease
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013


Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014

Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD?
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

LATE-BREAKING ABSTRACT: Awareness of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

Prevalence of chronic obstructive lung disease (COPD) in a industrial environment – the impact of occupational risk factors
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009


Optimising pharmacotherapy in patients with pulmonary arterial hypertension and comorbidities, including lung diseases and heart failure: benefits without harm?
Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Year: 2018


The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities)
Source: International Congress 2014 – Comorbidities
Year: 2014


Pulmonary hypertension and chronic lung disease: where are we headed?
Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019
Year: 2019



Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015